Onglyza and the Risks of Heart Failure and Pancreatic Cancer
Where you or a loved one harmed by Onglyza? This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm Researchers associate this Type 2 diabetes drug with some very serious complications. These include heart failure, pancreatitis, and pancreatic cancer. The national pharmaceutical practice group of The Michael Brady Lynch Firm is
Read More
The Michael Brady Lynch Firm Files Zofran Cleft Lip Lawsuit
For Immediate Release: August 20, 2015 Today, the nation mass tort litigation practice of The Michael Brady Lynch Firm filed a new lawsuit on behalf of a Massachusetts family against GlaxoSmithKline LLC in the United States District Court for Massachusetts. The family asserts that GSK’s anti-nausea prescription drug Zofran caused their daughter to be born
Read MoreJPML Approves MDL of Bard IVC Cases
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The case against the safety and effectiveness of the IVC filter just moved up a notch. The Judicial Panel on Multidistrict Litigation announced that all pending IVC Filter cases against C.R. Bard, Inc. and Bard Peripheral Vascular will be consolidated and
Read MoreThe Dangers of Heart Failure Associated with Onglyza
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. When Onglyza (saxagliptin) arrived on the marker in 2009, it was seen as a new frontier in maintaining blood sugar levels in type 2 diabetics. The excitement faded when the drug was linked to heart failure and other serious complications. These
Read More